Gene-vegetarianism interactions in calcium, estimated glomerular filtration rate, and testosterone identified in genome-wide analysis across 30 biomarkers

PLoS Genet. 2024 Jul 11;20(7):e1011288. doi: 10.1371/journal.pgen.1011288. eCollection 2024 Jul.

Abstract

We examined the associations of vegetarianism with metabolic biomarkers using traditional and genetic epidemiology. First, we addressed inconsistencies in self-reported vegetarianism among UK Biobank participants by utilizing data from two dietary surveys to find a cohort of strict European vegetarians (N = 2,312). Vegetarians were matched 1:4 with nonvegetarians for non-genetic association analyses, revealing significant effects of vegetarianism in 15 of 30 biomarkers. Cholesterol measures plus vitamin D were significantly lower in vegetarians, while triglycerides were higher. A genome-wide association study revealed no genome-wide significant (GWS; 5×10-8) associations with vegetarian behavior. We performed genome-wide gene-vegetarianism interaction analyses for the biomarkers, and detected a GWS interaction impacting calcium at rs72952628 (P = 4.47×10-8). rs72952628 is in MMAA, a B12 metabolic pathway gene; B12 has major deficiency potential in vegetarians. Gene-based interaction tests revealed two significant genes, RNF168 in testosterone (P = 1.45×10-6) and DOCK4 in estimated glomerular filtration rate (eGFR) (P = 6.76×10-7), which have previously been associated with testicular and renal traits, respectively. These nutrigenetic findings indicate genotype can modify the associations between vegetarianism and health outcomes.

MeSH terms

  • Adult
  • Aged
  • Biomarkers* / blood
  • Calcium* / metabolism
  • Diet, Vegetarian*
  • Female
  • Genome-Wide Association Study*
  • Glomerular Filtration Rate* / genetics
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Testosterone* / blood
  • Ubiquitin-Protein Ligases / genetics
  • Vegetarians
  • Vitamin D / blood

Substances

  • Testosterone
  • Biomarkers
  • Calcium
  • Vitamin D
  • Ubiquitin-Protein Ligases

Grants and funding

Research reported in this publication was supported by Foundation for the National Institutes of Health (T32GM007103 to MF), National Institute of General Medical Sciences (R35GM143060 to KY), National Institute of Diabetes and Digestive and Kidney Diseases (K01 DK133637 to KEW), National Heart, Lung, and Blood Institute (R01 HL145025 to KEW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.